Marpai appoints Dallas Scrip as COO effective June 2, 2025

Marpai, Inc.

Dallas Scrip appointed COO and President of MarpaiRx, effective June 2, 2025.
Base salary $250,000; 2025 bonus up to $125k if Company profitable by year-end.
300,000 RSUs vesting over three years; additional 100k RSUs upon $5M EBITDA target.
2026 bonus tiers: up to $250k if net income $7M and revenue $100M.
Scrip previously President of ValueHealth Benefit Administrators and Centivo.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dallas Scrip

Chief Operating Officer

MRAI · Marpai, Inc.

Effective: 2025-06-02
Filed: May 13, 2025, 7:59 PM ET

On May 13, 2025, the Board of Directors of Marpai, Inc. (the “Company”) appointed Dallas Scrip, age 42, as Chief Operating Officer of the Company, effective as of June 2, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dallas Scrip was appointed as Chief Operating Officer at Marpai, Inc..

Action: appointed
Role: Chief Operating Officer

Exact text from the filing

On May 13, 2025, the Board of Directors of Marpai, Inc. (the “Company”) appointed Dallas Scrip, age 42, as Chief Operating Officer of the Company, effective as of June 2, 2025.

View on SEC.gov

Marpai, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-25-042317

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.